GLP-1s, or glucagon-like peptide-1 receptor agonists, regulate blood sugar levels by increasing insulin release and slowing digestion
According to patient data, 1-month results often include 5 to 15 pounds of weight loss, improved energy, and measurable reductions in waist and hip measurements
doi: 10.1371/journal.pone.0047936 27 LiJ.ZhengJ.WangS.LauH
Why Tesamorelin May Be a Better Clinical Conversation Tesamorelin is FDA approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy, but it is not indicated for general weight loss management
If you want the specific injection protocol, our team covers it in detail in our guide to how to inject BPC-157, how much to take, and when to expect results based on the indication being treated